Glucose abnormalities in Asian patients with chronic hepatitis C

Glucose abnormalities in Asian patients with chronic hepatitis C

Qingyan Bo,1 Roberto Orsenigo,2 Junyi Wang,1 Louis Griffel,3 Clifford Brass3 1Beijing Novartis Pharma Co. Ltd., Shanghai, People’s Republic of China; 2Novartis Pharma AG, Basel, Switzerland; 3Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA Abstract: Many studies have demonstr...

Full description

Bibliographic Details
Main Authors: Bo Q, Orsenigo R, Wang J, Griffel L, Brass C
Format: Article
Language:English
Published: Dove Medical Press 2015-11-01
Series:Drug Design, Development and Therapy
Online Access:https://www.dovepress.com/glucose-abnormalities-in-asian-patients-with-chronic-hepatitis-c-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/glucose-abnormalities-in-asian-patients-with-chronic-hepatitis-c-peer-reviewed-article-DDDT

Similar Items